Early Intensive Hand Rehabilitation After Spinal Cord Injury: Effect of a novel muscle-stimulator device versus standard treatment on hand function in participants with spinal cord injury.

The University of Melbourne0 个研究点目标入组 78 人开始时间: 2009年8月12日最近更新: 2020年1月13日

适应症

试验速览

暂无简介。

•* have sustained a Spinal Cord Injury (SCI)within the preceding 6 months from time of consent
•* are currently receiving inpatient rehabilitation through one of the study sites
•* will remain in hospital for 12 weeks after initial screening
•* are 16 years of age or older and able to provide informed consent
•* have a motor complete or incomplete spinal cord injury at the neurological level of C2 to T1 (as per the International Standardised Neurological Assessment for SCI)
•* can actively flex their target shoulder to 60 degrees
•* have reduced ability to grasp using the target hand
•* are able to tolerate sufficient Functional Electrical Stimulation (FES) to enable one hand to grasp and release
•* have the potential to benefit from FES and ReJoyce according to the judgment of the treating therapist

•* have any other type of neurological injury affecting the target hand (e.g. brachial plexus or peripheral nerve injuries)
•* have had recent trauma or surgery to the target hand or upper limb within the last 12 months
•* have had amputation of any digits on the target hand
•* are not able to sit out of bed each day for at least 2 hours over three consecutive days
•* have extensive fixed contractures in the upper limb of the target hand preventing use of the ReJoyce
•* have severe spasticity in the target hand or upper limb preventing use of the ReJoyce
•* are unable to attend the 6-month and 1-year follow-up assessments at their treating spinal unit
•* are likely to undergo hand surgery in the target hand in the next year
•* are likely to experience autonomic dysreflexia and/or hypotension in response to electrical stimulation
•* have any contraindications to FES such as cardiac pacemaker, epilepsy, forearm fracture or pregnancy
•* have intracranial metal implants
•* have impaired vision and/or are unable to view a computer screen
•* have any other serious medical condition including malignancies, psychiatric, behavioural or drug-dependency problems, which are likely to influence the participant’s ability to cooperate or in the opinion of the study investigator would prevent the participant from adhering to the Protocol.

发起方